The course material includes the following sections: – Molecular Biology in Medicine – Molecular Biology and Personalised or Precision Medicine, Results of the Human Genome Project. – Genome structure and organization – Nucleosomes (structure, organisation, function), Interactions with proteins in centromeres and telomeres, Chromatin structure in the interphase nucleus, Organisation of genes in the genome, Types of genes, Repeat sequences, Scattered repeats, Transposable elements, Non-coding DNA. – Physicochemical properties of nucleic acids – Nucleic acids, DNA/ RNA structure, DNA/ RNA differences/similarities, Types of RNA, Transcriptome – DNA replication – DNA polymerases, Replication errors and proofreading activity of DNA polymerase, Replication machinery and its constituent enzymes (primases, helicases, topoisomerases), Telomers and telomerase. – DNA damage and repair – Types of DNA damage, Mutagenic agents (radiation, chemical agents), Basic mechanisms of damage repair (NHEJ, homologous recombination), Damage to repair mechanisms: the example of melanchromatic dry skin and classical progeria syndromes. – RNA transcription and processing – Structure and function of RNA polymerase; RNA species and RNA polymerases; Differences between eukaryotes and prokaryotes in transcription; Mechanism of transcription; Transcription factors (general, specific); Transcription of mitochondrial genes; Processing of RNA molecules; Splicing and alternative splicing: alternative splicing in familial hypercholesterolemia; MRNA degradation and exonuclease activity. – Translation – Transfer of genetic information from RNA to proteins, Redundant genetic code and the wobble or instability hypothesis, Translation initiation factors (elFs), Controlled protein degradation-structure and function of the ubiquitin-proteasome system and diseases: Autoimmune diseases, Parkinson’s disease, viral infections, cancer, Lysosome-dependent protein degradation, Post-translational modifications of proteins, RNA and origin of life, RNA-DNA evolution. – Regulation of gene expression in prokaryotes – Response to exogenous segments and modification of gene expression, Molecular switches, Basic structure and function of operon in prokaryotes (activators and repressors), Regulation of the lactose operon and the action of CAP protein, Regulation of the tryptophan operon and the concept of co-repressor, Secondary mechanism of operon regulation-transcriptional attenuation. – Regulation of gene expression in eukaryotes – Checkpoints in the transfer of genetic information from DNA to proteins, Transcriptional regulators and regulatory sequences; nuclear steroid hormone receptors and tamoxifen action, Activators and repressors of expression, Enhancers, Combinatorial control of gene expression and development. – Epigenetic regulation of gene expression – DNA methylation, histone modifications, large and small non-coding RNA molecules, Dysfunction of epigenetic mechanisms and disease pathogenesis, Small RNA interference (RNA interference/RNAi). – Mutations and polymorphisms – Types of mutations and their involvement in diseases: the example of sickle cell anaemia and cystic fibrosis, Polymorphisms (SNPs, STRs, VNTRs, CNVs), Polymorphisms as predisposing factors of diseases: Apolipoprotein E genotypes and Alzheimer’s disease, Polymorphisms and forensic DNA fingerprinting, Polymorphisms of mitochondrial DNA, Polymorphisms and drug response: example of polymorphisms in cytochrome P450 isoenzyme and antithrombotic therapy. – Stem cells and tissue homeostasis – Types and properties of stem cells, Method of reprogramming differentiated cells and production of induced stem cells, Cell cycle of adult stem cells, Damage to tissue signalling and induction of adult stem cell proliferation, Stem cells and cell therapy of diseases: Neurodegenerative and cardiovascular diseases, spinal cord injury, cancer, etc. α). – Molecular mechanisms of ageing of cells and organisms – Ageing as a response to damage accumulation, Milestones of ageing, Ageing as a barrier mechanism in carcinogenesis and as a risk factor for carcinogenesis. – Molecular Biology Technologies – Polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR), Southern blot, Northern blot, Sanger method, Role of molecular biology technologies in biomedical research and their importance in clinical practice – molecular diagnostics. – New technologies and applications in disease diagnosis – Next generation sequencing (NGS), Comparative analysis of genomes, Gene identification and function prediction, DNA microarrays and RNA-seq, Applications in the diagnosis of genetic diseases (cystic fibrosis etc.) and malignancies (solid tumours and haematological neoplasms). – Modern recombinant DNA technology – Recombinant DNA technology, Genetic engineering, DNA manipulation and analysis techniques (restriction nucleases). – Cloning – DNA cloning in bacteria – use of plasmids and transformation of bacteria, DNA library generation (genomic library and cDNA library). – Experimental animals as model organisms – Model organisms (Drosophila, C. elegans, mouse), Ways of creating transgenic, conditional transgenic and knock out mice, Contribution of transgenic organisms to elucidate biological processes in the aetiopathogenesis and treatment of diseases. Animal models of human diseases (Huntington’s disease, progeria, Zucker rats and obesity). – Evolution of genomes – Ways of generating genetic diversity, gene change, Natural selection pressure, evolution: lactose intolerance, The paradigm of horizontal gene transfer and antibiotic resistance, Homologous genes (highly conserved genes), Genetic drift, Parts of conserved synteny, Inadmissible and intolerable changes in the genome; purifying selection. – Carcinogenesis – Mechanisms of carcinogenesis, Oncogenes and tumour suppressor genes: the example of retinoblastoma, Loss of heterozygosity and microsatellite instability (MSI), Cancer stem cells and cancer transformation, New therapies in cancer. Laboratory Exercises (Two modules (Part A and B) conducted in 5 laboratory exercises) Part A : Diagnosis of sickle cell anaemia by Restriction Fragment Length Polymorphisms (RFLP) – Use of microplate – Isolation of genomic DNA from peripheral blood using columns – Amplification of part of the beta-globin gene by polymerase chain reaction (PCR) technique – PCR product segmentation using restriction endonucleases – Preparation of agarose gel and electrophoresis of digestion products in the gel – Evaluation of the result; diagnosis of sickle cell anaemia Part B: Serological Diagnostic Method-ELISA – Basic Principles of Immunological Response – Antibodies/Chemical Immunity – ELISA (Enzyme-Linked ImmunoSorbent Assay)-Detection of antibodies (e.g. against measles virus) |